The Canadian Medical Association has been leading a national conversation about healthcare transformation. Now, new funding is on the table. How confident are you that change is possible?
Douglas Clark, executive director of the Patented Medicine Prices Review Board, announced today he will be leaving his post after almost a decade with the regulator.